Page 1,553«..1020..1,5521,5531,5541,555..1,5601,570..»

Category Archives: Transhuman News

Modification of genes in human embryos could mark turning point in human evolution – The Globe and Mail

Posted: August 8, 2017 at 3:48 am

It appears, by all accounts, to be a momentous scientific achievement and possibly a turning point in human evolution. In a study released last week, scientists at Oregon Health and Science University confirmed they were able to modify genes in viable human embryos, proving the potential to permanently alter the makeup of a genetic line.

In this case, that meant replacing and repairing a mutated gene that causes a common and deadly heart disorder. But the possibilities heralded by gene-editing technology are endless, the scenarios as divided as they are bold. In some visions, it leads to a population of designer babies or consumer eugenics. Others imagine a utopia of scientific advancement where humans live free of disease, and devastating conditions are eradicated for the betterment of humanity. What direction the technology will take is the topic of much debate.

The big thing which is making the scientific and ethics community get excited, and on the other hand a little bit hot and bothered, is its a mechanism to change genes for multiple generations, says Dr. Alice Virani, a genetic counsellor and director of ethics at British Columbias Provincial Health Services Authority. There are two ways to look at it, the more realistic ramifications and the sci-fi, if-this-was-out-of-control ramifications.

Opinion: Gene editing is not about designer babies

The team at the Oregon universitys Center for Embryonic Cell and Gene Therapy used technology called CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, to repair or edit the gene carrying the heart disorder, seemingly with greater success than previous attempts by scientists in China.

News of the research has been anxiously anticipated by many in the field, both for what it means for the potential eradication of a disease such as hypertrophic cardiomyopathy and for the fundamental questions it raises about human reproduction, health and society.

When the study was leaked days before its publication in the journal Nature, its lead scientist, Dr. Shoukhrat Mitalipov, attributed the release to likely a combination of hot words: CRISPR, gene-editing, and designer babies.

The study and its combination of hot words didnt disappoint.

The New York Times hailed the milestone in research, while The New York Post cried BABE NEW WORLD and described an amazing and slightly terrifying breakthrough. A headline on Vox declared simply, This Is Huge.

Even actor Ashton Kutcher tweeted enthusiastically about the scientific breakthrough, writing: Scientists successfully used CRISPR to fix a mutation that causes disease. This is why I wanted to be a geneticist!

The tweet ignited among his followers the same range of responses that are always so keenly tied to the issue of changing human genes, from hope that devastating conditions such as muscular dystrophy will be eradicated, to fear about the unknown consequences of playing God.

Dr. Timothy Caulfield, a Canada Research Chair in Health Law and Policy and professor at the University of Alberta, says the polarized and dramatic response he has seen in recent days reminds him of early reaction to stem-cell science, where, he says, It was either going to be cloned armies, or we were going to eradicate all disease.

In fact, neither has turned out to be the case, and so it may be with gene editing as well.

We need to be cautious not to hype the benefits and be cautious not to hype the ethical concerns, he says. There are real issues on both sides of the debate but lets make sure our discourse is evidence-formed.

He described the new research as a genuinely exciting area, and said the potential of CRISPR which is used not only in human genetics, but also has potentially revolutionary applications for agriculture, animals, plants and food has introduced both exciting possibilities and reasons for deep policy reflection.

Erika Kleiderman, a lawyer and academic whose work focuses on gene-editing technologies, stem-cell research and regenerative medicine at the Centre of Genomics and Policy at McGill University, says the Oregon teams research is exciting because it confirms the ability of CRISPR technology to repair genetic mutations, and establishes the basic safety of the technique in a research context. And while she said people often go straight to thinking about the potential for manipulating genes to create so-called designer babies, a concept that is cool but also quite frightening, the medical implications could be equally staggering, and are far more likely.

For example, something like Huntington disease, she says. Being able to prevent that or treat that one day, in my opinion, would be a fantastic leap for our scientific knowledge and medical advancement. That being said, people will raise the eugenics argument. Is that a possibility? Yes. Are we close to that? I dont think so.

Canada has strict laws around genetic modification and editing, and altering genes in a way that could be passed on to future generations is a criminal offence under the Assisted Human Reproduction Act, punishable with fines up to $500,000 or 10 years in prison.

But as the technology takes a large step forward, Ms. Kleiderman and Dr. Caulfield and are among a group of Canadian scientists and academics calling for less regulation around genetic science and research in Canada, not more.

Both were involved in the creation of an editorial published in the journal Regenerative Medicine in January calling for new consideration of the issues and ethics involved in gene editing, and a revision of Canadian legal policy.

A criminal ban is a suboptimal policy tool for science as it is inflexible, stifles public debate, and hinders responsiveness to the evolving nature of science and societal attitudes, the editorial read. It was signed by seven other experts and ethicists, and came out of a think tank on the future of human gene editing in Canada held at McGill last summer.

Dr. Caulfield says legal prohibition of certain genetic research doesnt make sense when we dont yet know or understand where the science is going, or what the benefits or harms could be. Instead, he says he believes in regulation in problematic areas, while allowing for studies and trials. He says that some of the slippery slope scenarios people fear such as using genetic modification for human enhancement and to achieve superficial traits such as height remain distant possibilities given the complexity of the science.

That is not to say there are not risks or issues to be addressed as the technology continues to evolve. Ms. Kleiderman says that includes consideration of the potential risk to future generations, the safety of the technology and other irrevocable, if unintended, consequences, although she says those risks are not unique to gene modification but true of all technologies.

When it comes to CRISPR, one of the areas it would be most beneficial is with the treatment of prevention of disease which I think most people would be in agreement with, she says. Of course, we need to be mindful of doing not-so-positive things with it, like going down the enhancement route.

She said other potential issues, such as the preservation of human diversity and individuality, the welfare of children born from this technology and the potential for creating new forms of inequality, discrimination or societal conflict, all require significant consideration and research.

There is time. Although the technology is moving quickly, there is still a long way before gene editing is used in clinical human trials. Even after that, Dr. Virani says for the foreseeable future the technology will most likely be used by a small group of people in specific scenarios related to the prevention of serious genetic disease.

Im not saying we shouldnt be concerned about those potential issues, but sometimes we make that leap too quickly, she said. We dont necessarily [think] that the most likely scenario is that couples will use this technology on a very limited basis if they know their child may potentially have a devastating genetic condition. Thats not something that suddenly everyone is going to start to do. I think theres sometimes that leap to, Oh, we can create designer babies, but I think were very much in the lessening-burden-of-disease phase rather than the designer-baby phase, though thats where peoples minds go.

Dr. Virani said one of her own concerns is the possibility of off-target effects, where changing a gene unexpectedly alters something else in the genome. Other concerns are more social reality than science fiction, including that the technology and the ability to prevent disease may only be available to those who can pay for it. Eradicating a horrible disease is one thing. Eradicating it only for families who can afford it is another.

So is it going to look like just the wealthy are going to be able to afford this type of technology? she asks. Thats very problematic in my eyes from an ethics point of view, and thinking about fairness in society. If only poor people get Huntington disease, then the lobby to support Huntington disease research is greatly diminished. Its kind of like a two-fold negative effect.

On Thursday, the American Journal of Human Genetics ran a policy statement signed by 11 organizations from around the world, including the Canadian Association of Genetic Counsellors, urging a cautious but pro-active approach as the science moves forward. The statement includes an agreement that gene editing should not yet be performed in embryos carried on to human pregnancy. (The embryos used in the Oregon research were created only for the research, and were not developed further.) It also outlines a number of criteria that should be met before clinical trials take place, and supports public funding for the research. The U.S. government does not allow federal funding for genetic research on embryos. The Oregon research was funded by the university.

We dont want it to go speeding ahead, said Kelly Ormond, the lead author of the policy statement and a genetics professor at Stanford University in California. We want people to be very transparent about whats happening and we want things to undergo good ethics review, and for society to actually be engaged in these dialogues now while this research is just starting to happen.

She said she believes its important to be pro-active in talking and thinking about the issues related to the technology, and starting a broader conversation of how gene editing should and will be used.

We can all agree that that world [of eugenics and designer babies] doesnt feel very comfortable, and I think most of us dont want to go there, she said. So we need to find ways to prevent that from happening.

Follow Jana G. Pruden on Twitter: @jana_pruden

Link:
Modification of genes in human embryos could mark turning point in human evolution - The Globe and Mail

Posted in Human Genetics | Comments Off on Modification of genes in human embryos could mark turning point in human evolution – The Globe and Mail

Big data yields surprising connections between diseases – Medical Xpress

Posted: at 3:48 am

August 7, 2017 New disease classifications created by analyzing genetic and environmental correlations among family members. Credit: Kanix Wang, et al

Using health insurance claims data from more than 480,000 people in nearly 130,000 families, researchers at the University of Chicago have created a new classification of common diseases based on how often they occur among genetically-related individuals.

Researchers hope the work, published this week in Nature Genetics, will help physicians make better diagnoses and treat root causes instead of symptoms.

"Understanding genetic similarities between diseases may mean that drugs that are effective for one disease may be effective for another one," said Andrey Rzhetsky, PhD, the Edna K. Papazian Professor of Medicine and Human Genetics at UChicago who was the paper's senior author. "And for those diseases with a large environmental component, that means we can perhaps prevent them by changing the environment."

The results of the study suggest that standard disease classifications-called nosologies-based on symptoms or anatomy may miss connections between diseases with the same underlying causes. For example, the new study showed that migraine, typically classified as a disease of the central nervous system, appeared to be most genetically similar to irritable bowel syndrome, an inflammatory disorder of the intestine.

Rzhetsky and a team of researchers analyzed records from Truven MarketScan, a database of de-identified patient data from more than 40 million families in the United States. They selected a subset of records based on how long parents and their children were covered under the same insurance plan within a time frame most likely to capture when children were living in the same home with their parents. They used this massive data set to estimate genetic and environmental correlations between diseases.

Next, using statistical methods developed to create evolutionary trees of organisms, the team created a disease classification based on two measures. One focused on shared genetic correlations of diseases, or how often diseases occurred among genetically-related individuals, such as parents and children. The other focused on the familial environment, or how often diseases occurred among those sharing a home but who had no or partially matching genetic backgrounds, such as spouses and siblings.

The results focused on 29 diseases that were well represented in both children and parents to build new classification trees. Each "branch" of the tree is built with pairs of diseases that are highly correlated with each other, meaning they occur frequently together, either between parents and children sharing the same genes, or family members sharing the same living environment.

"The large number of families in this study allowed us to obtain precise estimates of genetic and environmental correlations, representing the common causes of multiple different diseases," said Kanix Wang, a graduate student at UChicago and lead author of the study. "Using these shared genetic and environmental causes, we created a new system to classify diseases based on their intrinsic biology."

Genetic similarities between diseases tended to be stronger than their corresponding environmental correlations. For the majority of neuropsychiatric diseases, such as schizophrenia, bipolar disorder and substance abuse, however, environmental correlations are nearly as strong as genetic ones. This suggests there are elements of the shared, family environment that could be changed to help prevent these disorders.

The researchers also compared their results to the widely used International Classification of Diseases Version 9 (ICD-9) and found additional, unexpected groupings of diseases. For example, type 1 diabetes, an autoimmune endocrine disease, has a high genetic correlation with hypertension, a disease of the circulatory system. The researchers also saw high genetic correlations across common, apparently dissimilar diseases such as asthma, allergic rhinitis, osteoarthritis and dermatitis.

Explore further: Diseases that run in families not all down to genes, study shows

More information: Classification of common human diseases derived from shared genetic and environmental determinants, Nature Genetics (2017). DOI: 10.1038/ng.3931

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

See the original post here:
Big data yields surprising connections between diseases - Medical Xpress

Posted in Human Genetics | Comments Off on Big data yields surprising connections between diseases – Medical Xpress

New look at archaic DNA rewrites human evolution story – Phys.Org

Posted: at 3:48 am

August 7, 2017 These population trees with embedded gene trees show how mutations can generate nucleotide site patterns. The four branch tips of each gene tree represent genetic samples from four populations: modern Africans, modern Eurasians, Neanderthals, and Denisovans. In the left tree, the mutation (shown in blue) is shared by the Eurasian, Neanderthal and Denisovan genomes. In the right tree, the mutation (shown in red) is shared by the Eurasian and Neanderthal genomes. Credit: Alan Rogers, University of Utah

Hundreds of thousands of years ago, the ancestors of modern humans diverged from an archaic lineage that gave rise to Neanderthals and Denisovans. Yet the evolutionary relationships between these groups remain unclear.

A University of Utah-led team developed a new method for analyzing DNA sequence data to reconstruct the early history of the archaic human populations. They revealed an evolutionary story that contradicts conventional wisdom about modern humans, Neanderthals and Denisovans.

The study found that the Neanderthal-Denisovan lineage nearly went extinct after separating from modern humans. Just 300 generations later, Neanderthals and Denisovans diverged from each other around 744,000 years ago. Then, the global Neanderthal population grew to tens of thousands of individuals living in fragmented, isolated populations scattered across Eurasia.

"This hypothesis is against conventional wisdom, but it makes more sense than the conventional wisdom." said Alan Rogers, professor in the Department of Anthropology and lead author of the study that will publish online on August 7, 2017 in the Proceedings of the National Academy of Sciences.

A different evolutionary story

With only limited samples of fossil fragments, anthropologists assemble the history of human evolution using genetics and statistics.

Previous estimates of the Neanderthal population size are very smallaround 1,000 individuals. However, a 2015 study showed that these estimates underrepresent the number of individuals if the Neanderthal population was subdivided into isolated, regional groups. The Utah team suggests that this explains the discrepancy between previous estimates and their own much larger estimate of Neanderthal population size.

"Looking at the data that shows how related everything was, the model was not predicting the gene patterns that we were seeing," said Ryan Bohlender, post-doctoral fellow at the M. D. Anderson Cancer Center at the University of Texas, and co-author of the study. "We needed a different model and, therefore, a different evolutionary story."

The team developed an improved statistical method, called legofit, that accounts for multiple populations in the gene pool. They estimated the percentage of Neanderthal genes flowing into modern Eurasian populations, the date at which archaic populations diverged from each other, and their population sizes.

A family history in DNA

The human genome has about 3.5 billion nucleotide sites. Over time, genes at certain sites can mutate. If a parent passes down that mutation to their kids, who pass it to their kids, and so on, that mutation acts as a family seal stamped onto the DNA.

Scientists use these mutations to piece together evolutionary history hundreds of thousands of years in the past. By searching for shared gene mutations along the nucleotide sites of various human populations, scientists can estimate when groups diverged, and the sizes of populations contributing to the gene pool.

"You're trying to find a fingerprint of these ancient humans in other populations. It's a small percentage of the genome, but it's there," said Rogers.

They compared the genomes of four human populations: Modern Eurasians, modern Africans, Neanderthals and Denisovans. The modern samples came from Phase I of the 1000-Genomes project and the archaic samples came from the Max Planck Institute for Evolutionary Anthropology. The Utah team analyzed a few million nucleotide sites that shared a gene mutation in two or three human groups, and established 10 distinct nucleotide site patterns.

Against conventional wisdom

The new method confirmed previous estimates that modern Eurasians share about 2 percent of Neanderthal DNA. However, other findings questioned established theories.

Their analysis revealed that 20 percent of nucleotide sites exhibited a mutation only shared by Neanderthals and Denisovans, a genetic timestamp marking the time before the archaic groups diverged. The team calculated that Neanderthals and Denisovans separated about 744,000 years ago, much earlier than any other estimation of the split.

"If Neanderthals and Denisovans had separated later, then there ought to be more sites at which the mutation is present in the two archaic samples, but is absent from modern samples," said Rogers.

The analysis also questioned whether the Neanderthal population had only 1,000 individuals. There is some evidence for this; Neanderthal DNA contains mutations that usually occur in small populations with little genetic diversity.

However, Neanderthal remains found in various locations are genetically different from each other. This supports the study's finding that regional Neanderthals were likely small bands of individuals, which explains the harmful mutations, while the global population was quite large.

"The idea is that there are these small, geographically isolated populations, like islands, that sometimes interact, but it's a pain to move from island to island. So, they tend to stay with their own populations," said Bohlender.

Their analysis revealed that the Neanderthals grew to tens of thousands of individuals living in fragmented, isolated populations.

"There's a rich Neanderthal fossil record. There are lots of Neanderthal sites," said Rogers. "It's hard to imagine that there would be so many of them if there were only 1,000 individuals in the whole world."

Rogers is excited to apply the new method in other contexts.

"To some degree, this is a proof of concept that the method can work. That's exciting," said Rogers. "We have remarkable ability to estimate things with high precision, much farther back in the past than anyone has realized."

Explore further: DNA of early Neanderthal gives timeline for new modern human-related dispersal from Africa

More information: Alan R. Rogers el al., "Early history of Neanderthals and Denisovans," PNAS (2017). http://www.pnas.org/cgi/doi/10.1073/pnas.1706426114

Ancient mitochondrial DNA from the femur of an archaic European hominin is helping to resolve the complicated relationship between modern humans and Neanderthals. The genetic data recovered by the research team, led by scientists ...

Relationships between the ancestors of modern humans and other archaic populations such as Neanderthals and Denisovans were likely more complex than previously thought, involving interbreeding within and outside Africa, according ...

The Neanderthals disappeared about 30,000 years ago, but little pieces of them live on in the form of DNA sequences scattered through the modern human genome. A new study by geneticists at the University of California, Davis, ...

Using several different methods of DNA analysis, an international research team has found what they consider to be strong evidence of an interbreeding event between Neanderthals and modern humans that occurred tens of thousands ...

Most non-Africans possess at least a little bit Neanderthal DNA. But a new map of archaic ancestrypublished March 28 in Current Biologysuggests that many bloodlines around the world, particularly of South Asian descent, ...

The last Neanderthal died 40,000 years ago, but much of their genome lives on, in bits and pieces, through modern humans. The impact of Neanderthals' genetic contribution has been uncertain: Do these snippets affect our genome's ...

A team of Japanese scientists has developed a way to make and sell a type of ice cream that does not melt, capitalizing on a discovery made accidentally by a chef. Most ice cream starts melting just moments after it is scooped ...

Japan's attack on Pearl Harbor in 1941 drew the United States into World War II and spawned a massive wave of shock and fear across the country. It also prompted the U.S. government to round up and send more than 100,000 ...

An often cited claim that humans, who are smarter and more technologically advanced than their ancestors, originated in response to climate change is challenged in a new report by a Center for the Advanced Study of Human ...

A study of more than 2,500 people provides new evidence about the effects of luminance on the quality and consistency of our financial decision-making.

Having lost their heads, been pulled from their plinths, smashed and even buried, things are at last looking up for some of the unluckiest statues in Christendom.

Comedian George Carlin's 1972 routine "the seven words you can never say on television" underlined his generation's rejection of the niceties and constraints of post-war American society. Seeing how the use of these swear ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Here is the original post:
New look at archaic DNA rewrites human evolution story - Phys.Org

Posted in Human Genetics | Comments Off on New look at archaic DNA rewrites human evolution story – Phys.Org

DNA in 1994 murder points to serial rapist, not 2 men serving life … – Chicago Tribune

Posted: at 3:47 am

New forensic testing suggests two men serving life sentences for a 1994 rape and murder in Chicago were wrongfully convicted because DNA from the victim's underwear is linked to a serial rapist, a petition filed Monday in Cook County court alleges.

The DNA from the underwear matches the serial rapist, who is not named in the filing, with "almost scientific certainty," the filing states. DNA found under the victim's fingernails and on her sweatshirt does not match the men serving time for the crime, but the serial rapist could not be excluded as the source of that DNA, the petition said.

The Cook County state's attorney's office said it is doing an "intense review and investigation" into the case and is awaiting more DNA results.

A jury convicted Nevest Coleman and Darryl Fulton in the April 1994 rape and murder of Antwinica Bridgeman about three years after the crime.

At the time of the slaying, Coleman worked as a respected, well-liked member of the groundskeeping crew at Comiskey Park, court records show. Fulton lived near Coleman in Englewood.

Bridgeman had just celebrated her 20th birthday at a small gathering with friends attended by Coleman. She disappeared that night and was discovered weeks later in Coleman's basement.

Illinois Department of Corrections

Coleman and a friend found Bridgeman's body with a piece of concrete in her mouth and a pipe in her vagina.

Both Coleman, 25, and Fulton, 27, gave police confessions implicating themselves and another man in the crime. The two later said their confessions were coerced, and the third man would not give a statement after denying any involvement. Prosecutors dropped the charges against the third man.

Coleman's attorney Russell Ainsworth, with the Exoneration Project at the University of Chicago Law School, filed a motion Monday to temporarily vacate Coleman's sentence and have him released on bond pending the state's reinvestigation of the case. It also seeks to eventually have Coleman's conviction vacated.

Ainsworth's motion states that the "sole evidence" against Coleman was the confession, and his background did not fit with a rapist and murderer.

Coleman had no criminal history before Bridgeman's killing.

Judge Dennis Porter heard the original case in 1997 and also considered Ainsworth's argument on Monday. He delayed a ruling until Aug. 18 while prosecutors file a written argument against Ainsworth's motion.

Mark Rotert, head of the Cook County State's Attorney's Conviction Integrity Unit, told the judge "we're not there yet" regarding vacating the sentence, and asked for more time.

More DNA testing is being done, and it could take months to sort out, Ainsworth said.

Fulton is represented by Kathleen Zellner, a Downers Grove attorney who has handled numerous wrongful conviction cases.

Nicholas Curran, one of Zellner's associates, attended Monday's hearing and said he is in favor of giving prosecutors more time.

Coleman will be transported from prison to attend the next hearing.

Ainsworth's motion details forensic reports that, he says, clear his client and Fulton.

A forensic report dated May 31 of this year notes Coleman, Fulton, the third man and Bridgeman's boyfriend were all excluded as the source of semen collected from the victim's underwear, the filing alleges.

A July 21 forensic report notes Coleman, Fulton, the third man and Bridgeman's boyfriend were also excluded as the source of semen collected from the victim's sweatshirt, but that stain could not exclude the serial rapist, the filing states.

Coleman also "testified that his confession was the product of coercion and false promises," the filing alleges.

Detectives involved with the case have subsequently seen some of their cases fall apart by DNA testing, the filing said.

The recent DNA testing blows a hole through the government's theory of what happened in this crime, Ainsworth said.

For Coleman and Fulton to have raped and murdered Bridgeman, the filing notes, "the victim would have to had consensual sex with a serial rapist (who was not her boyfriend), sex that left his semen on her underwear and sweatshirt, and then Mr. Coleman, Mr. Fulton and (the third man) subsequently raped the victim without leaving any of their DNA on her underwear, sweatshirt or fingernails."

After the hearing, a spokeswoman for State's Attorney Kim Foxx released a statement saying the case "remains the subject of an intense review and investigation by the Cook County State's Attorney's Office Conviction Integrity Unit."

Prosecutors are awaiting additional DNA results and have asked for an expedited examination from the laboratory. They "will continue to approach the investigation of Mr. Coleman and Mr. Fulton's convictions with urgency, and remain in contact with their counsel as the investigation proceeds," officials said.

Coleman's relatives filled a bench in the courtroom during Monday's hearing. Coleman's brother, Micquel, was in court alongside their sister Jennice. Micquel said he'll host Nevest at his Evanston home if he's freed.

Nevest Coleman has maintained his innocence since day one, his siblings noted. The family became emotional while listing the events he's missed while locked up, including the death of his parents.

"We just want him out," Jennice Coleman said.

Coleman's two children, Chanequa and Nicholas, who are 25 and 23, also came to support their father. The children described Coleman as an attentive dad even behind bars, asking about what's going on in their lives and offering advice.

"I feel like he's here, but he's not," Nicholas Coleman said.

gpratt@chicagotribune.com

Twitter @royalpratt

See the original post here:
DNA in 1994 murder points to serial rapist, not 2 men serving life ... - Chicago Tribune

Posted in DNA | Comments Off on DNA in 1994 murder points to serial rapist, not 2 men serving life … – Chicago Tribune

Man Killed in 9/11 Attacks Is Identified by DNA Testing – New York Times

Posted: at 3:47 am

The remains of a man who was killed in the Sept. 11 terrorist attacks on the World Trade Center have been positively identified, the New York City medical examiners office announced on Monday, amid continuing efforts to return victims remains to their loved ones.

The man, whose name was withheld by officials at his familys request, was the first Sept. 11 victim to be identified in more than two years.

Recent improvements to how DNA is extracted and tested helped confirm the mans identity late last month after years of negative results, the medical examiners office said Monday. He was the 1,641st person to be positively identified of the 2,753 people killed when the twin towers were destroyed.

Dr. Barbara Sampson, the citys chief medical examiner, said forensic scientists had continued to test the remains as more advanced methods had become available. The vast majority of named victims were identified using DNA or a combination of techniques, according to city data. Positive identification of the remains, which are mostly bone fragments, allows victims families to finally claim what is left of their loved ones.

This ongoing work is vital because with each new identification, we are able to bring answers to families affected by tremendous loss, Dr. Sampson said.

More:
Man Killed in 9/11 Attacks Is Identified by DNA Testing - New York Times

Posted in DNA | Comments Off on Man Killed in 9/11 Attacks Is Identified by DNA Testing – New York Times

Questions over DNA tests sold for nutritional advice – CBS News – CBS News

Posted: at 3:47 am

Every time Rebecca Castle sat down to eat her favorite foods, she says she suffered excruciating abdominal pain.

"I cut out carbs. I wasn't eating dairy," she said. Nevertheless, she experienced sharp, shooting pain, bloating and distention for more than two years.

Castle saw multiple doctors. Then she spent several hundred dollars to take a DNA metabolic test.

What she learned? "I was allergic to starch," she said. "That's mostly root vegetables, corn, peas, sweet potatoes."

Nutritionist Nicci Schock says a typical client for such a DNA test is an athlete looking to improve performance. "And then folks like Rebecca, they know their body and they know something is off."

Proponents of metabolic tests say dietary recommendations are based on a patient's genetic profile.

Nutrigenomix

Ahmed El-Sohemy, the chief science officer at Nutrigenomix, said, "Even though it's a genetic test, it's effectively dietary advice and counseling an individual on how to eat better.

"Individual genetic differences can help us understand why some people respond differently from others."

Nutrigenomix markets a DNA test that looks at 45 genetic markers. The company makes recommendations based on the patient's genetic profile, pointing out attributes like "an elevated risk for low iron."

"We're talking about metabolic tests," El-Sohemy told correspondent Michelle Miller. "They're genetic tests, but they affect the way that you metabolize various substances that you consume."

But Dr. David Agus, a CBS News contributor, says DNA tests for diet and exercise recommendations are not validated by medical research.

"There are very few of them that actually have data behind them," he said. "And to me, that's a problem. You know, you have companies like 23andMe that were taken off the market for several years because they had to show data with regard to human disease. Well, I think this same thing needs to happen with nutrition and exercise."

The FDA says it supports tests "that may provide consumers with direct genetic information that can inform health related decisions."

But the agency points out it "does not actively regulate these products."

"2,400 years ago, Hippocrates did something amazing: he would eat something, and he would write down how he felt after he ate it," Dr. Agus said. "To me, that's the best way in the world to know what's right for you."

Rebecca Castle says the test produced more than 30 pages of results about her body, which means she can now avoid the foods that set off her stomach.

"I think it's worth it," she said. "You don't need your blood taken; you're literally just spitting into a test tube. You could do it in your sleep!"

2017 CBS Interactive Inc. All Rights Reserved.

See the rest here:
Questions over DNA tests sold for nutritional advice - CBS News - CBS News

Posted in DNA | Comments Off on Questions over DNA tests sold for nutritional advice – CBS News – CBS News

Company Claims DNA Test Can Predict Dietary Problems CBS … – CBS New York

Posted: at 3:47 am

NEW YORK (CBSNewYork) When it comes to finding a perfect meal plan or diet, the answer could be as simple as checking your DNA.

As CBS2s Dr. Max Gomez reported, several companies are jumping on the nutrigenomics bandwagon the emerging science of how nutrition interacts with your individual DNA.

Every time Rebecca Castle sat down to eat her favorite food, she says she suffered excruciating abdominal pain.

Yeah its terrible, terrible, like, sharp shooting pain, bloating, distention, she said.

That pain went on for more than two years. Castle saw multiple doctors and then took a saliva DNA metabolic test.

I was allergic to starch, she said. Thats mostly root vegetables, corn, peas, sweet potatoes.

Ahmed El-Sohemy is the chief scientific officer at Nutrigenomix.

Individual genetic differences can help us understand why some people respond differently from others, El-Sohemy said.

Nutrigenomix says their DNA test looks at a persons 45 genetic markers. The company makes recommendations based on the patients genetic profile, pointing out attributes like an elevated risk for low iron.

Were talking about metabolic tests, El-Sohemy said. Theyre genetic tests, but they affect the way that you metabolize various substances that you consume.

Dr. David Agus is a CBS News contributor.

DNA tests for diet and exercise just are not validated, Agus said. There are very few of them that actually have data behind them.

The Nutrigenomix website cites a number of stories in the lay press, but CBS2 could not find any scientific stories that supported the companys claims.

A recent journal article said that a definite association between the genes usually examined in nutrigenomics testing and several diet-related diseases is lacking.

The company website has a disclaimer in very small print: Nutrigenomix reports are for information purposes only and are not intended to be used as medical advice.

Still, Castle said the test worked for her,

I think its worth it, she said. You dont need your blood taken. Youre literally just spitting into a test tube.

There is a kernel of science behind the interaction of nutrition and genetics. Bu the ability to use your own genome to predict how you will respond to specific nutrients that science is not there yet.

The tests run about $300 to $500 and are not covered by insurance.

Original post:
Company Claims DNA Test Can Predict Dietary Problems CBS ... - CBS New York

Posted in DNA | Comments Off on Company Claims DNA Test Can Predict Dietary Problems CBS … – CBS New York

Scientists Reprogram Cells’ DNA Using Nanotechnology – Voice of America

Posted: at 3:47 am

Researchers have turned skin cells into blood vessel tissue to save a mouse's wounded leg. They were able to do that simply by tapping the wound with a chip that uses nanotechnology to inject new DNA into the cells.

This step follows a number of significant advances in techniques to turn one type of cell into another. Scientists hope this so-called cell reprogramming can one day be used to regenerate damaged tissue, or cure conditions such as Parkinson's disease.

The research, published Monday in Nature Nanotechnology, combines existing biotechnology and nanotechnology to create a new technique called tissue nano-transfection. The researchers turned skin cells into brain cells, in addition to demonstrating the therapeutic benefit of turning them into vascular cells.

Maintaining blood flow to deliver nutrients around a wound is critical for recovery, so by making more blood vessel cells, researchers found that a mouse's wounded limb was more likely to survive.

A brief electric current causes the chip to eject DNA fragments that reprogram the cells. The particles only enter the very top layer of cells, so L. James Lee, a biomolecular engineer at Ohio State University and study co-author, said he was surprised to find reprogrammed cells deep within the tissue.

"Within 24 hours after the transfection, we actually observed the propagation of the biological functions deep inside the skin," Lee told VOA. "So we were very surprised that it actually works for tissue." Lee said it wasn't yet entirely clear why this was possible.

Masato Nakafuku, who studies cell reprogramming at the University of Cincinnati and was not associated with the research, told VOA that he, too, was surprised "to see very efficient generation of the [vascular] cells."

Nakafuku added a cautionary note: It is not clear that that tissue nano-transfection will work on animals as large as humans, since the treatment would have to reprogram cells much deeper in the tissue in order to be effective.

Lee told VOA he is hopeful that upcoming human trials will prove the real-world effectiveness of tissue nano-transfection.

In theory, tissue nano-transfection should be able to turn any cell in the body into any other cell type. That could make therapeutic applications of cell reprogramming easier and safer, because cells would stay in the body during reprogramming. If cells are removed from the body, reprogrammed and then returned, they could be attacked by the immune system.

Go here to read the rest:
Scientists Reprogram Cells' DNA Using Nanotechnology - Voice of America

Posted in DNA | Comments Off on Scientists Reprogram Cells’ DNA Using Nanotechnology – Voice of America

Researchers retract a paper when they realize they had sequenced the wrong snail’s genome – Retraction Watch (blog)

Posted: at 3:47 am

Researchers in China thought they had sequenced the genomes of two snails that help transmit diseases to other species an important first step to stopping the spread. But their hopes were soon dashed after they realized they had misidentified one of the snails.

The researchers published their findings earlier this year in the journal Parasites & Vectors. In the paper, the authors stressed that understanding the genetic makeup of these molluscs is important because many freshwater snails are intermediate hosts for flatworm parasites and transmit infectious diseases to humans and other animals. They also acknowledged that identifying snail species from their appearance alone can be tricky.

Indeed, not long after the study was published, a reader raised concerns that the authors had misidentified one of the snails. After re-examining their data, the authors realized their mistake: They had not checked their results against a genome database, called Basic Local Alignment Search Tool (BLAST), which compares biological sequences against known ones and finds regions of similarity. If they had, the authors may have discovered they had sequenced the wrong species.

Heres theretraction notice for The complete mitochondrial genomes of two freshwater snails provide new protein-coding gene rearrangement models and phylogenetic implications, published in January 2017:

The authors are retracting this article [1]. A reader recently raised questions related to the identification of one of the snail species whose complete mitochondrial (mt) genomes have been characterised in our article, because the gene order and mt genome sequence of the sample of Radix swinhoei (family Lymnaeidae) strongly resemble those of Physella acuta (family Physidae) (GenBank JQ390525.1 and JQ390526.1) published by Nolan et al. [2].

The initial morphology-based identification of the snail as Radix swinhoei was not tested with BLAST searches and as a result we did not realise that we had characterised the mitochondrial genome of a different species. Upon re-examination of our data, we suggest that the sample Radix swinhoei does in fact represent a species of Physella (referred to as Physella sp.). Because of this misidentification and the fact that the phylogenetic analysis did not include members of the family Physidae, the conclusions drawn from the Radix swinhoei sample in our article are incorrect.

All authors agree with this retraction.

We contacted the papers corresponding author, Yinchan Hu, based at the Chinese Academy of Fishery Sciences in the Ministry of Agriculture in Guangzhou, as well as the first author, Xidong Mu, and second-to-last author, Hongmei Song, both based at the same institution. We will update the post if we hear back.

Hat tip: Rolf Degen

Like Retraction Watch? Consider making a tax-deductible contribution to support our growth. You can also follow us on Twitter, like us on Facebook, add us to your RSS reader, sign up on our homepage for an email every time theres a new post, or subscribe to our daily digest. Click here to review our Comments Policy. For a sneak peek at what were working on, click here.

See the original post:
Researchers retract a paper when they realize they had sequenced the wrong snail's genome - Retraction Watch (blog)

Posted in Genome | Comments Off on Researchers retract a paper when they realize they had sequenced the wrong snail’s genome – Retraction Watch (blog)

Veritas Genetics Scoops Up an AI Company to Sort Out Its DNA – WIRED

Posted: at 3:47 am

Genes carry the information that make you you . So it's fitting that, when sequenced and stored in a computer, your genome takes up gobs of memoryup to 150 gigabytes. Multiply that across all the people who have gotten sequenced, and you're looking at some serious storage issues. If that's not enough, mining those genomes for useful insight means comparing them all to each other, to medical histories, and to the millions of scientific papers about genetics .

Sorting all that out is a perfect task for artificial intelligence . And plenty of AI startups have bent their efforts in that direction. On August 3, sequencing company Veritas Genetics bought one of the most influential: seven-year old Curoverse. Veritas thinks AI will help interpret the genetic risk of certain diseases and scour the ever-growing databases of genomic, medical, and scientific research. In a step forward, the company also hopes to use things like natural language processing and deep learning to help customers query their genetic data on demand.

It's not totally surprising that Veritas bought up Curoverse. Both companies spun out of George Church's prolific Harvard lab . Several years ago, Church started something called the Personal Genomics Project, with the goal of sequencing 100,000 human genomesand linking each one to participants' health information. Veritas' founders helped lead the sequencing partstarting as a prenatal testing service and launching a $1,000 full genome product in 2015while Curoverse worked on academic strategies to store and sort through all the data.

But more broadly, genomics and AI practically call out for one another. As a raw data format, a single person's genome takes up about 150 gigabytes. How!?! OK so, yes, storing a single base pair only takes up around two bits. Multiply that by roughly 3 billionthe total number of base pairs in your 23 chromosome pairsand you wind up with around 750 megabytes. But genetic sequencing isn't perfect. Mirza Cifric, Veritas Genetics cofounder and CEO, says his company reads each part of the genome at least 30 times in order to make sure their results are statistically significant. "And you gotta keep all that data, so you can refer back to it over time," says Cifric.

That's just storage. "Everything after that is going to specific areas and asking questions: Theres a variant at this location, a substitution of this base, a deletion here, or multiple copies of this same gene here, here, and here," says Cifric. Now, interpret all that. Oh, and do it across a thousand, hundred thousand, or million genomes. Querying all those genetic variations is how scientists get leads to find new drugs, or figure out how existing drugs work differently on different people.

But cross-referencing all those genomes is just the beginning. Curoverse, which was focusing on projects to store and sort genomic data, also has its work cut out for it in searching through the 6 millionand countingjargon-filled academic papers detailing gene behavior, including visual information found in charts, graphs, and illustrations.

That's pretty ambitious. Natural language processing is one of the stickiest problems in AI . "Look, I am a computer scientist, I love AI and machine learning, and no amount of coding makes sense to solve this," says Atul Butte , the director of UCSF's Institute of Computational Health Sciences. At his former job at Stanford University, Butte actually tried to do the same thinguse AI to dig through genetics research. He says in the end, it was way cheaper to hire people to read the papers and input the findings into his database manually.

Bahar Gholipour

Artificial Intelligence Could Dig Up Cures Buried Online

Megan Molteni

Artificial Intelligence Is Learning to Predict and Prevent Suicide

Anna Vlasits

AI Could Target Autism Before It Even EmergesBut It's No Cure-All

But hey, never say never, right? However they accomplish it, Veritas wants to move past what companies like 23andMe and Color offer: genetic risk based on single-variant diseases. Some of America's biggest dangers come from diseases like diabetes and heart disease, which are activated by interactions between multiple genesin addition to environmental factors like diet and exercise. With AI, Cifric believes Veritas will be able to not only dig up these various genetic contributors, but also assign each a statistical score showing how much it contributes to the overall risk.

Again, Butte hates to be a spoilsport, but ... there's all sorts of problems with doing predictive diagnostics with genetic data. He points to a 2013 study that used polygenic testing to predict heart disease using the Framingham Heart Study dataabout as good as you can get, when it comes to health data and heart disease. "They authors showed that yes, given polygenic risk score, and blood levels, and lipid levels, and family history, you can predict within 10 years if someone will develop heart disease," says Butte. "But doctors could do the same thing without using the genome!"

He says the problems come down to just how messy it is trying to square up all the different research on each gene alongside the environmental risks, and all the other compounding factors that come up when you try to peer into the future. "Its been the holy grail for a long time, structured genome reporting," says Butte. Even attempts to get researchers to write and report data in a standard, machine-readable way, have fallen flat. "You get into questions that never go away. One researcher defines autism different from another one, or high blood pressure, or any number of things," he says.

Butte isn't a total naysayer. He says partnerships like the one between Veritas and Curoverse are becoming more commonlike the data processing deal between genetic sequencing giant Illumina and IBM Watsonbecause there's a clear need for new computing methods in this area. "You want to get to a point where you are developing stuff that improves clinical care," he says.

Or how about directly to the owners of the genomes? Cifric hopes the merger will improve the consumer experience of using genetic data, even seamlessly integrating it into daily life. For instance, linking your genome and health records to your digital assistant. Alexa, should I eat this last piece of pizza? Maybe you should skip it, depending on your baseline genetic risk for cholesterol and latest blood test results. Diet isn't the only area where genomics could help improve your day to day life. Some people are more or less sensitive to over the counter drugs. A quick query might tell you whether you should take a little less Tylenol than is recommended.

Cifric thinks this acquisition could position Veritas as a global powerhouse of genomic data. "Apple recently announced that they had shipped 41 million iPhones in a quarter, right? I think in not too distant future, well be doing 41 million genomes in a quarter," he says. That might seem ambitious, given that the cost to consumers is nearly $1,000. But that cost is bound to come down. And artificial intelligence will make paying for the genome a matter of common sense.

This story has been updated to reflect that the company is named Veritas Genetics, not Veritas Genomics.

Go here to see the original:
Veritas Genetics Scoops Up an AI Company to Sort Out Its DNA - WIRED

Posted in Genome | Comments Off on Veritas Genetics Scoops Up an AI Company to Sort Out Its DNA – WIRED

Page 1,553«..1020..1,5521,5531,5541,555..1,5601,570..»